About

Operators who’ve done this from the inside.

We spent our careers leading biometrics teams at Roche, Genentech, Gilead, Alector and others. We started working together in 2024, and founded TrapezoidX on one belief: early-stage biotech deserves a better class of clinical data analytics partner.

Nalin Tikoo, MS

Co-founder, President & CEO

Strategic operational leader: visual data analytics, PK-PD and safety analytics, computing environments and AI adoption.

Leadership roles at: Roche/Genentech · Alector · BioMarin
Therapeutic areas: Oncology · Neuroscience · Rare disease

LinkedIn →

Vijay Kumar, MS

Co-founder, Strategic Advisor

Technical and regulatory expert: FDA submissions, CDISC data standards, computing environments and AI adoption.

Leadership roles at: Gilead · Aimmune
Therapeutic areas: Virology · Oncology/Hematology · Immunology

Senior people do the work: 20+ years each in early-stage clinical data analysis and reporting, including FDA submissions. Backed by a partner network in biostatistics, pharmacovigilance and clinical pharmacology.

Continuity is built in. All code is documented and reproducible in our system, so no deliverable depends on one person.

What clients say

“TrapezoidX enabled us to explore our data in a more dynamic fashion, allowing us to make nimble, data-based decisions, while maintaining the integrity of the overall study.”

CMO, Series B Biotech

“They are dependable problem-solvers who deliver clean, accurate analyses with precision. Beyond their technical skills, they offer valuable strategic insights.”

Biostatistics Consultant, Series B Biotech

Talks and publications

We share what we learn.

BBSW 2025 · TalkLeveraging AI and R for Efficient Clinical Trial Reporting: A Phase I Case Study. Tikoo, Kumar.

BBSW 2024 · TalkHarmonizing Complexity: Navigating the Evolving Landscape of CDISC Standards to Elevate Biomarker Data. Tikoo, Huang.

BBSW 2023 · TalkThe Rise of Biomarker Data in Drug Development: Are You Ready? Tikoo, Huang.

BBSW 2023 · PosterIDEAS: Interactive Data Exploration & Analysis System, a Spotfire-based visual analytics platform. Tikoo, Callahan.

BMC Cancer · 2020Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in advanced NSCLC. Jiang et al.

Clin Cancer Res · 2020Disease monitoring using post-induction circulating tumor DNA analysis following first-line therapy in metastatic colorectal cancer. Ma et al.

J Mol Diagn · 2020Concordance of genomic alterations by NGS in tumor tissue versus cell-free DNA in stage I–IV NSCLC. Jiang et al.

Also: PhUSE US Connect 2018, ESMO 2018 and WUSS 2010. Full list on request.

Talk to the people who’ll do the work.

A 30-minute scoping call, under NDA from day one.

Book a scoping call Prefer to write? Send us a note →